Betahistine Mesylate

Betahistine Mesilate dilates the precapillary sphincters, and this increases blood flow in the inner ear. It controls how permeable the capillaries of the inner ear are, which removes endolymphatic hydrops. It also improves cerebral circulation by increasing blood flow in the internal carotid artery. For these reasons, Betahistine Mesylate is clinically useful for relieving vertigo and dizziness. In short, it increases microcirculation blood flow in the inner ear, clears the endolymphatic hydrops there, and significantly increases blood flow in the internal carotid artery. For discomfort that goes with cerebral disturbances, betahistine has a marked healing effect on giddiness felt on standing, the sensation of instability and symptoms of dizziness. The heavy feeling in the head and the discomforts that come with it can also be subdued successfully. For dizziness and the sensation of dizziness due to disturbances in the inner ear, betahistine improves microcirculation of the inner ear and removes endolymph hydrops, so it relieves dizziness in Meniere's disease and Meniere's syndrome. Tinnitus, the sensation of ear obstruction, nausea and vomiting are also effectively eased. For the prevention of dizzy spells and other residual symptoms, it inhibits the symptoms of dizziness and removes residual symptoms after an attack. Continued use of Betahistine Mesylate also prevents dizzy spells from coming back. When betahistine is the primary choice in prescribing for dizziness, it can be combined with antihypertensive agents, therapeutic agents for arteriosclerosis, vitamins and tranquilizers. With this combined use, the accompanying symptoms can also be brought into remission and better therapeutic effects obtained.